Security readout for executives and security teams
Plain-English summary
This CVE affects Dräger Infinity Delta, Delta XL, and Kappa patient monitors. An unauthenticated attacker on a reachable network can access log files that may reveal device internals, physical location details, and wired network configuration. It is a confidentiality issue, not a documented patient-monitor control or availability issue.
Executive priority
Treat this as a moderate medical-device privacy and network-mapping risk. It should be prioritized in hospitals or clinics with flat networks or legacy patient-monitor deployments, but current sources do not justify emergency treatment as an actively exploited or life-safety-impacting vulnerability.
Technical view
The vulnerability is CWE-538: insertion of sensitive information into externally accessible files. Listed affected products are Dräger Infinity Delta, Delta XL, and Kappa across all software versions. CVSS v4.0 is 5.3 with adjacent-network, low-complexity, no-privilege, no-user-interaction access and limited vulnerable-system confidentiality impact.
Likely exposure
Exposure is most relevant where these monitors are reachable from clinical, biomedical engineering, or adjacent hospital networks without strong segmentation. Internet exposure is not stated in the sources. Organizations without current asset inventory for legacy bedside monitors may have difficulty confirming affected deployments quickly.
Exploitation context
The source bundle does not show CISA KEV listing or cited active exploitation. The issue requires network reachability and no authentication, so misuse is plausible inside poorly segmented environments. Available evidence supports information disclosure only, not code execution, device takeover, or service disruption.
Researcher notes
Do not assume impact beyond exposed logs. Sources identify disclosure of internals, location information, and wired network configuration details. No patch, workaround, exploit availability, or exploitation-in-the-wild evidence is provided in the bundle, so validation should focus on asset presence, reachability, and vendor guidance.
Mitigation direction
- Review Dräger security guidance for product-specific remediation or compensating controls.
- Inventory Infinity Delta, Delta XL, and Kappa monitors in clinical networks.
- Restrict monitor management and log access to trusted administrative networks.
- Segment patient-monitor networks from user, guest, and general corporate networks.
- Monitor for unusual access attempts to device log resources.
Validation and detection
- Confirm whether affected Dräger monitor models are deployed.
- Record software versions and network segments for each device.
- Verify whether devices are reachable from non-clinical or untrusted networks.
- Review network telemetry for unexplained log access attempts.
- Check vendor advisory updates before deciding remediation status.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-538: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2019-25717 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Medium
- CVSS
- 5.3 (4.0)
- Known Exploited
- No
- Published
Vector: CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
SSVC decision data
CVSS vector scores
2 official scoresWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N——VulnCheckCVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N2.81.4VulnCheckVulnerability scoring details
Base CVSS 4.0 score
5.3MediumVector: CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N
Base CVSS 3.1 score
4.3MediumVector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
- CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
- CVE publishedCVE Program
The CVE record was published.
- CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.
ADP provider summaries
Source materials
- CVE List V5 sourceCVE List V5
- https://static.draeger.com/securityCVE reference, VulnCheck · vendor-advisory
- https://www.vulncheck.com/advisories/dr-ger-infinity-delta-kappa-patient-monitors-unauthenticated-log-file-disclosureCVE reference, VulnCheck · third-party-advisory
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Insertion of Sensitive Information into Externally-Accessible File or Directory
Insertion of Sensitive Information into Externally-Accessible File or Directory represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.